A trailblazer in retinal diseases, Dr. Richard Spaide has pioneered numerous "firsts" in the field, notably the development of autofluorescence imaging using a fundus camera and groundbreaking techniques in optical coherence tomography. These innovations are now globally recognized and employed. With a repertoire of surgical instruments named after him and holding patents for ophthalmic inventions, Dr. Spaide's contributions are vast and impactful. His accolades encompass prestigious awards like the Richard and Hilda Rosenthal Foundation Award, the Senior Honor Award from the American Society of Retinal Surgeons, and the revered Roger H. Johnson Macular Degeneration Award. As the top author in retinal research, his seminal article "Retinal Vascular Layers Imaged by Fluorescein Angiography" stands out as the most cited in the past decade. Serving on numerous medical boards and editorial roles, including his current position as Associate Editor of the journal Retina, Dr. Spaide's dedication to advancing ophthalmology is unparalleled. His foundational training from Muhlenberg College, Jefferson Medical College, and esteemed fellowships reinforce his standing as a leading voice in retina and eye care.

A cornerstone of the Retina & Eye community, Dr. Ronald Frenkel founded the East Florida Eye Institute in 1989 and has been instrumental in advancing ophthalmological care on the Treasure Coast. Specializing in conditions such as Cataracts, Diabetic Retinopathy, and Macular Degeneration, Dr. Frenkel's commitment to excellence ensures patients receive cutting-edge care. A former professor at the prestigious Bascom Palmer Eye Institute, his achievements include the Distinguished Alumni Award from Kresge Eye Institute and the American Academy of Ophthalmology's Achievement Award. With distinguished training, including a Glaucoma Fellowship at Harvard, Dr. Frenkel's contributions to the field, both as a speaker and a researcher in over 90 clinical trials, position him as a luminary in retina and eye care.

Dr. Michael W. Stewart stands as a beacon of expertise in the realm of ophthalmology, with a particular focus on retinal detachment, diabetic retinopathy, and macular degeneration. Serving as the Chair of Ophthalmology in Florida, Dr. Stewart is deeply involved in pioneering research and treatment methodologies. His association with the Mayo Clinic further underscores his commitment to excellence and innovation in eye care.

Dr. Stewart's rich educational background, including fellowships at the University of California, Davis, and the Retina Research Foundation, equips him with a profound understanding of vitreoretinal diseases. He has been recognized with prestigious awards, such as the Nataraja Pillai Orator Award and the President's Award from the Florida Society of Ophthalmology, reflecting his dedication to the field. His active involvement as a Board Member of the International Council on Accreditation of Allied Health Programs in Ophthalmology and his role as Secretary of Education for the Joint Commission on Allied Health Personnel in Ophthalmology showcase his leadership and commitment to shaping the future of ophthalmology.

With over five decades of unwavering dedication to ophthalmology, Dr. Lee Jampol stands as a testament to excellence and innovation in eye care. Currently practicing at Northwestern Medical Group and affiliated with the renowned Northwestern Memorial Hospital in Chicago, IL, Dr. Jampol's vast experience spans both clinical and academic realms.

​

A proud alumnus of Yale University, where he completed both his medical degree and residency, Dr. Jampol's foundation in ophthalmology is rooted in world-class education and training. His commitment to advancing the field is further evidenced by his numerous accolades, including recognition as a Regional Top Doctor by Castle Connolly and receiving the Meaningful Use Stage 1 Certification from the Centers for Medicare & Medicaid Services.

​

Beyond his clinical expertise, Dr. Jampol is deeply involved in the academic sphere, nurturing the next generation of ophthalmologists and contributing to the broader knowledge base of the field. His legacy in ophthalmology is not just built on his exceptional patient care but also on his enduring commitment to education, research, and the broader medical community.

Dr. Charles C. Wykoff is a distinguished figure in the world of ophthalmology, seamlessly blending clinical expertise with a passion for research and innovation. As the Director of Research at Retina Consultants of Texas and Chairman of Research for Retina Consultants of America, he is at the forefront of groundbreaking studies and advancements in retinal care.

​

Dr. Wykoff's illustrious educational journey includes esteemed institutions like Harvard Medical School, Massachusetts Institute of Technology, and the Bascom Palmer Eye Institute in Miami, where he completed his retinal fellowship and residency. His relentless pursuit of knowledge has led to the development of novel instruments for vitrectomy surgery, aiming to refine surgical procedures and address challenges in the field.

​

With an unwavering commitment to improving outcomes for blinding diseases, Dr. Wykoff has published over 250 peer-reviewed manuscripts, contributing significantly to the global understanding of retinal disorders. His affiliations with organizations like the Vit-Buckle Society, where he serves as the President, and his roles on the ASRS Board of Directors and the Ophthalmology Retina Editorial Board, further cement his position as a leader in retina and eye care.

​

A visionary and a scholar, Dr. Wykoff's dedication to translational research, coupled with his clinical acumen, positions him as a beacon of excellence in the ever-evolving landscape of ophthalmology.

Dr. Daniela Ferrera is a luminary in ophthalmology, merging her deep-rooted South American heritage with global advancements in eye care. A proud graduate of the Federal University of Rio de Janeiro, Brazil, one of South America's leading institutions, Dr. Ferrera's medical journey reflects a blend of dedication, innovation, and passion.

​

With a foundation in macromolecular metabolism research during her medical school years, she has continually pushed the boundaries of knowledge. Her Master's Degree focused on the electrophysiology of chromatic vision, and her subsequent PhD in Visual Sciences delved into multimodal imaging on retinal dystrophy, showcasing her commitment to understanding the intricacies of the human eye.

​

In 2006, Dr. Ferrera transitioned to the United States, undertaking a research fellowship in Medical Retina at the Manhattan Eye, Ear & Throat Hospital affiliated with New York University. Since then, her expertise in multimodal imaging analysis for clinical trials on retinal diseases has been instrumental in shaping the field. Currently, as an Assistant Professor of Ophthalmology at Tufts University School of Medicine, she collaborates closely with the Optical Coherence Tomography Team, bridging the gap between retina specialists and the innovative Research Laboratory of Electronics from the Massachusetts Institute of Technology.

​

A beacon of inspiration and knowledge, Dr. Ferrera's career is a testament to her dedication to both basic research and clinical challenges, making her a pivotal figure in the global ophthalmology community.

A board-certified ophthalmologist with over 24 years of experience, Dr. Steven Vold is a recognized innovator in the field. Based in Northwest Arkansas, he specializes in complex glaucoma, cataract diagnosis and treatment, and pioneering laser vision correction techniques. He is known for his dedication to patient satisfaction and his consistent presence in the Consumer’s Research Council of America’s Guide to America’s Top Ophthalmologists since 2002.

​

Dr. Vold's professional contributions are significant. He is the Chief Medical Editor of Glaucoma Today and co-founder of the American-European Congress of Ophthalmic Surgery. A prolific contributor to the field, he has co-founded medical device company Ocunetics, Inc., and played pivotal roles in the creation and implementation of numerous innovative products in the market. Dr. Vold’s achievements are punctuated by being the first surgeon in the U.S. to perform multiple advanced eye surgeries, solidifying his reputation as a trailblazer.

​

Skilled in a wide array of treatments, he excels in laser retina surgery, refractive and cataract surgeries, and a host of other eye procedures. His commitment to pushing boundaries has seen him introduce treatments like SMILE laser treatment in Arkansas.

​

A recipient of multiple accolades including the American Academy of Ophthalmology Achievement Award and various "first surgeon" distinctions, Dr. Vold continues to be a prominent figure in ophthalmic circles, both for his surgical expertise and his commitment to advancing the field.

​

Dr. Vold serves at Washington Regional Medical, Mercy Hospital, and Northwest Medical Center.

Christina Rapp Prescott, MD, PhD, a distinguished cornea and cataract surgeon, has joined NYU Langone Health’s Department of Ophthalmology as the Vice Chair for Education and Director of the Cornea Service. Dr. Prescott, an associate professor at NYU Grossman School of Medicine, brings a wealth of experience in anterior segment surgery, with a focus on complex cataract and corneal procedures in both children and adults.

​

Previously serving as an assistant professor at Johns Hopkins Medicine's Wilmer Eye Institute, Dr. Prescott's expertise is a significant addition to the faculty at NYU Langone. Her collaboration with Dr. Kathryn A. Colby, chair of ophthalmology, is poised to enhance the training of future ophthalmologists and elevate patient care standards.

​

In her new role, Dr. Prescott aims to revitalize the Ophthalmology Residency program's surgical curriculum. This includes introducing advanced simulators, multiple practice laboratories, and specialized faculty mentorship, ensuring a comprehensive and hands-on learning experience for residents.

​

Dr. Prescott's educational journey began with a BA in biophysics from Columbia College, followed by a combined PhD/MD program at the University of Colorado Health Sciences Center in Denver. It was during this period that she discovered her passion for ophthalmology. Her subsequent internship and residency at Yale School of Medicine, and a cornea fellowship at Massachusetts Eye and Ear Infirmary under Dr. Colby, further solidified her career path.

​

Throughout her career, Dr. Prescott has been an active participant in the ophthalmology community, presenting at national and international conferences, collaborating internationally, and contributing to a plethora of research publications. Her dedication to advancing corneal surgery techniques and nurturing clinical expertise among her colleagues is evident in her work.

​

Dr. Carl D. Regillo, an esteemed figure in the field of ophthalmology, currently leads the Retina Service at Wills Eye Hospital and serves as a Professor of Ophthalmology at Thomas Jefferson University School of Medicine. His journey in ophthalmology is marked by significant achievements and contributions, making him a prominent expert, particularly in retinal diseases.

​

A valedictorian graduate from Northeastern University's College of Pharmacy and a Phi Kappa Phi honoree, Dr. Regillo paved his way to Harvard Medical School, graduating with his medical degree on a full military scholarship. He completed his internal medicine internship at Harvard’s Brigham and Women’s Hospital and further specialized in ophthalmology through residency and vitreoretinal fellowship at Wills Eye Hospital, Philadelphia. During his residency, he was named Co-Chief Resident and awarded the prestigious Heed Ophthalmic Fellowship.

​

Dr. Regillo’s early professional tenure included serving as a Major in the United States Air Force and a vitreoretinal surgeon at the San Diego Naval Medical Center. His leadership skills shone as he co-directed the Ophthalmology Department’s Retina Service and served as an Assistant Professor of Ophthalmology at the University of California, San Diego. His dedication was recognized with a Naval Commendation Medal and an annual teaching award.

Upon returning to Philadelphia in 1998, Dr. Regillo joined Mid Atlantic Retina and the Retina Service of Wills Eye Hospital. His roles expanded over the years, leading him to become the Director of the Wills Eye Clinical Retina Research Unit and Chairman of both the Institutional Review Board and the American Academy’s Basic and Clinical Science Course (BCSC) Retina Section committee. He also served as the Wills Retina Fellowship Program Director.

​

Dr. Regillo’s contribution to ophthalmology is extensive. He has authored over 300 scientific papers, delivered lectures both nationally and internationally, and published 9 major textbooks. His editorial roles include serving on boards for several distinguished ophthalmology journals. A fellow of the American College of Surgeons, Dr. Regillo actively participates in multiple prestigious ophthalmology societies and has received numerous accolades, including lifetime achievement awards and recognition as one of the top 100 most influential people in ophthalmology.

​

His commitment to advancing retinal care is evident through his leadership in major international clinical trials focusing on macular degeneration, diabetic retinopathy, and various retinal conditions. Named a “Top Doctor” for over two decades and recognized among the top ophthalmologists in the US, Dr. Regillo's impact on the field is both profound and inspiring.

David A. Goldman, M.D., embodies a blend of exceptional expertise and innovation in the field of ophthalmology. His illustrious journey began with an impressive academic foundation, earning a BA in Psychology, cum laude with distinction in all subjects from Cornell University, followed by an MD with honors in research from Tufts School of Medicine. He honed his medical skills during his internship in Internal Medicine at Cabrini Medical Center and further specialized in Ophthalmology with a residency and fellowship in Cornea and External Disease at the Bascom Palmer Eye Institute.

​

In his professional career, Dr. Goldman has held significant positions, including serving as the Medical Director at New York Eye and Ear/Mount Sinai West Palm Beach from 2017 to 2018 and as the Anterior Segment Team Lead at Modernizing Medicine since 2012. His tenure as an Assistant Professor of Clinical Ophthalmology at Bascom Palmer Eye Institute in Palm Beach Gardens highlighted his profound knowledge and skill in the field.

Dr. Goldman's dedication and skill have been recognized with numerous prestigious awards and honors. He was named one of the top 250 US surgeons by Premier Surgeon in 2010 and has been acknowledged as one of the top 40 under 40 ophthalmologists worldwide by The Ophthalmologist in 2015. Consistently featured in the list of Best Doctors and Top Ophthalmologists since 2012, his expertise was also recognized by Newsweek, ranking him as one of the best ophthalmologists in the United States.

A respected figure in the academic sphere, Dr. Goldman has contributed immensely to several editorial boards, including Refractive Eye Care, Advanced Ocular Care, Cataract and Refractive Surgery Today, Millennial Eye, and Ocular Surgery News. His insights and knowledge have been shared at numerous conferences as a keynote speaker and panelist, showcasing his leadership in the field.

Dr. Goldman’s approach to patient care combines technical brilliance with a compassionate, patient-focused philosophy. His active participation in various societies, editorial roles, and consistent presence in national and international ophthalmology conferences reflect his commitment to advancing the field. We are thrilled to welcome Dr. David A. Goldman as a key figure at the Vail Retina & Eye CME Conference, where his extensive achievements and visionary approach to ophthalmology will undoubtedly inspire and enlighten our community.

Christopher Anderson is a Chambers ranked health care transactional and regulatory attorney who works with professional healthcare providers,

telehealth/health tech companies, private equity funds, venture capitalists, strategic investors, lenders, and life science companies in connection

with planning, structuring, and executing transactions and other strategic business arrangements in the healthcare and life sciences industries.

His transactional experience also includes M&A, divestitures, joint ventures and other affiliations, corporate reorganizations, and financings. He

regularly leads large-scale transactions managing a team of subject matter experts as well as acting as a health care regulatory and transactional

authority in other firm deals.

His hospital-physician integration experience encompasses transactions for health systems, ASCs (ambulatory surgery centers), large physician

groups, and other ancillary providers, as well as the formation of care coordination entities, joint ventures, pay-for-performance and gain sharing

programs, co-management agreements, ACOs (accountable care organizations), clinically integrated networks, and other partnership opportunities

He has structured innovative arrangements between for-profit entities and nonprofit providers and/or quasi-governmental entities that has led to

the preservation of community health care assets and simultaneously safeguarded investor value.

Mr. Anderson’s regulatory practice includes advising clients on various fraud and abuse and self-referral matters, HIPAA and other data security

compliance issues, and Medicare program requirements as well as state licensure, certificate of need, corporate practice of medicine, and fee-split

problems.

Chris co-chairs the healthcare provider transaction subgroup and the virtual and digital health subgroup. He has written and spoken extensively on

the applications of health care law and is an adjunct professor at the University of Illinois-Chicago leading an annual class on health care law and

regulation.